Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 151,009 |
Total Actual Volume | 3,501,402 |
Short Trends | |
---|---|
Cover Days | 11 |
Short Days | 7 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 7,550 |
Average Short Percentage | 37.71% |
Is there a PLX Short Squeeze or Breakout about to happen?
See the PLX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-06-30 | 1.08 | 1.09 | 1.09 | 1.04 | 146,319 | 32,124 | 96.4308 |
2022-06-29 | 1.07 | 1.08 | 1.08 | 1.05 | 161,873 | 8,122 | 94.5078 |
2022-06-28 | 1.1 | 1.07 | 1.12 | 1.07 | 106,024 | 1,098 | 45.4282 |
2022-06-27 | 1.1 | 1.11 | 1.11 | 1.09 | 75,830 | 68 | 0.5982 |
2022-06-24 | 1.08 | 1.09 | 1.1299 | 1.0799 | 137,099 | 750 | 62.2407 |
2022-06-23 | 1.0989 | 1.1 | 1.11 | 1.08 | 114,260 | 1,600 | 28.7925 |
2022-06-22 | 1.07 | 1.09 | 1.12 | 1.07 | 81,518 | 100 | 1.8612 |
2022-06-21 | 1.07 | 1.081 | 1.12 | 1.06 | 231,080 | 13 | 0.2312 |
2022-06-17 | 1.1 | 1.09 | 1.1 | 1.08 | 82,594 | 2,120 | 13.6492 |
2022-06-16 | 1.07 | 1.06 | 1.08 | 1.04 | 188,033 | 12,123 | 54.4683 |
2022-06-15 | 1.09 | 1.08 | 1.0902 | 1.07 | 96,377 | 72 | 2.1133 |
2022-06-14 | 1.08 | 1.07 | 1.088 | 1.06 | 192,697 | 198 | 2.2735 |
2022-06-13 | 1.08 | 1.09 | 1.11 | 1.07 | 213,223 | 6,626 | 34.3298 |
2022-06-10 | 1.12 | 1.12 | 1.145 | 1.09 | 152,701 | 18,046 | 50.6228 |
2022-06-09 | 1.14 | 1.12 | 1.155 | 1.12 | 309,431 | 28,003 | 62.5360 |
2022-06-07 | 1.14 | 1.14 | 1.17 | 1.13 | 300,954 | 10,659 | 80.7317 |
2022-06-06 | 1.22 | 1.17 | 1.25 | 1.14 | 179,861 | 4,360 | 33.6446 |
2022-06-03 | 1.23 | 1.24 | 1.26 | 1.21 | 285,938 | 10,808 | 34.3427 |
2022-06-02 | 1.16 | 1.24 | 1.25 | 1.16 | 263,037 | 4,092 | 13.8839 |
2022-06-01 | 1.21 | 1.2 | 1.21 | 1.17 | 182,553 | 10,027 | 41.4356 |
Protalix BioTherapeutics Inc. Company Name:
PLX Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Protalix BioTherapeutics Appoints Shmuel "Muli" Ben Zvi, Ph.D. to its Board of Directors PR Newswire CARMIEL, Israel , June 30, 2022 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), announced today that the Company's Board ...
Protalix BioTherapeutics Announces Poster Presentations at the 2022 Program: 7th Update on Fabry Disease PR Newswire CARMIEL, Israel , May 26, 2022 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical com...
Protalix BioTherapeutics Reports First Quarter 2022 Financial and Business Results PR Newswire Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , May 16, 2022 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NY...